Regenall is a recognized leader in clinical research
We’re based in United Kingdom proudly affiliated with the Clinical Trials Unit, Faculty of Medicine, University of Kelaniya, Sri-Lanka and Clinical one (UK)
Regenall, an oral medication, is at the forefront of regenerative solutions for tendon, ligament, and muscle injuries in equines and humans.
Our commitment to excellence is evident through significant improvements showcased in clinical and ultrasonographic parameters in rigorous clinical trials.
why us?
Key Features
CLINICAL EXPERTISE:
At Regenall, our team of specialists guides your recovery journey, carefully assessing your progress
to provide personalized recommendations.
GLOBAL IMPACT
We've made our mark in international multicenter studies, consistently demonstrating excellence in recruitment and retention metrics.
CERTIFICATIONS
As an ISO 9001:2015 and ISO 27001:2013 certified company, we adhere to the highest standards in quality management and information security.
TEAM STRENGTH
Our team comprises 100+ full-time staff collaborating with 300+ investigators across 80+ Investigator centers.
AUDIT EXCELLENCE
We've undergone 40+ client and regulatory audits with no major or critical findings reported, showcasing our commitment to transparency and compliance.
Prof. Hilali Noorden
Founder and CEO
Medical expert in spinal deformities and tissue regeneration•Professor of Orthopaedic Spinal Surgery•8 granted tech patents worldwide
Prof.
Chris Lavy
Board Member
Medical Director for Regenall expansion into human commercialization•Professor of Othopaedic and Tropical Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Richard
Tyrone
Board Member
Acclaimed horseman with accomplishments across breeding and training horses•Managed the RegenallTM trial for chronic tendon/ligament injuries
Prof. Arjuna da Silva
Board Member
Consultant PhysicianColombo North TeachingHospital.
Dr. Amir
Pakravan
Board Member
Leading Sports Physician and Director Regenall.•Global reputation and Leader in Musculoskeletal medicine. Author and Director of Regenall Human Tendon trial•Secretary General European College of Sport and Exercise Physicians
Roger
Smith
Board Member
Professor of Equine Orthopaedics at the Royal Veterinary College•Leader across veterinary sports medicine with a PhD for studies on extracellular matrix of equine tendon
Prof. Hilali Noorden
Founder and CEO
Medical expert in spinal deformities and tissue regeneration•Professor of Orthopaedic Spinal Surgery•8 granted tech patents worldwide
Richard
Tyrone
Board Member
Acclaimed horseman with accomplishments across breeding and training horses•Managed the RegenallTM trial for chronic tendon/ligament injuries
Roger
Smith
Board Member
Professor of Equine Orthopaedics at the Royal Veterinary College•Leader across veterinary sports medicine with a PhD for studies on extracellular matrix of equine tendon
Prof. Hilali Noorden
Founder and CEO
Medical expert in spinal deformities and tissue regeneration•Professor of Orthopaedic Spinal Surgery•8 granted tech patents worldwide
Prof.
Chris Lavy
Board Member
Medical Director for Regenall expansion into human commercialization•Professor of Othopaedic and Tropical Surgery at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Prof. Arjuna da Silva
Board Member
Consultant PhysicianColombo North TeachingHospital.
Dr. Amir
Pakravan
Board Member
Leading Sports Physician and Director Regenall.•Global reputation and Leader in Musculoskeletal medicine. Author and Director of Regenall Human Tendon trial•Secretary General European College of Sport and Exercise Physicians
let's talk
Have any questions?
Have you experienced tendon or ligament injuries in yourself or your horse? Let's discuss.
Elevating Equine and Human Tendon and
Ligament Care to New Heights
Ligament Care to New Heights
COPYRIGHT © 2024 — REGENALL